Search

Search Constraints

You searched for: Author/Creator Sokol, Harry

Search Results

1. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Issue 10 (October 2016)

2. Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug. Issue 10 (December 2019)

3. A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations. Issue 11 (November 2019)

5. Diet‐Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice. Issue 12 (10th October 2018)

6. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. (May 2020)

8. Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines. Issue 3 (April 2020)

9. Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed. Issue 3 (April 2020)